A Closer Look at the Pricing Strategy Behind Biogen's Aduhelm
BioSpace
JULY 11, 2021
Adulhelm's proposed price tag of $56,000 per patient per year is hardly the most expensive drug on the market, but controversy regarding packaging and pricing continues.
Let's personalize your content